Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy for Unresectable, Locally Advanced, Stage 3 NSCLC: KEYNOTE-799.

S K Jabbour,K H Lee,N Frost,V Breder,D Kowalski, I Alawin,E Levchenko,N Reguart,A Martinez-Marti,B Houghton, J B Paoli, S Safina, K Park, T Komiya, A Sanford, V Boolell,H Liu,A Samkari,S Keller, M Reck

International journal of radiation oncology, biology, physics（2021）

引用 1|浏览2

暂无评分

摘要

Pembro + cCRT continues to demonstrate promising antitumor activity, and manageable toxicity in pts with previously untreated, locally advanced, stage III NSCLC with longer follow-up.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要